Retatrutide Research

Retatrutide Molecular Weight

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-233 cited sources

The short answer

Retatrutide's molecular weight is reported as approximately 4,731.33 Da for formula C221H342N46O68. That figure is consistent across most sources but is not verifiable against PubChem, which has no retatrutide record, and at least one reference gives a different formula entirely.

Key facts

Commonly reported MW
~4,731.33 Da
Commonly reported formula
C221H342N46O68
Alternative reported
C228H350N48O66, ~4,894.58 Da
PubChem verification
Not possible (no record)
Residues
39
For comparison: tirzepatide
4,813 Da, verified
For comparison: semaglutide
4,114 Da, verified

The figure and its provenance

4,731.33 Da appears across supplier catalogues and reference aggregators, with formula C221H342N46O68. It is consistent enough to be the working figure, and it is what previous versions of these articles stated. What was not stated is that it cannot be checked against a primary chemical database, because no retatrutide entry exists in PubChem under any of its names.

Where the disagreement sits

At least one reference source gives C228H350N48O66 at approximately 4,894.58 Da, a difference of roughly 163 Da, which is far too large to be rounding. Two formulae cannot both describe one molecule. Without a database entry to arbitrate, the discrepancy simply stands, and anyone relying on the mass should know it exists.

Research material referenced

Retatrutide 10mg, third-party HPLC tested

Buy Retatrutide · £59.99

Why this matters for calculations

Molarity is mass divided by molecular weight, so a 163 Da uncertainty propagates directly into any molar concentration. It is a smaller error than the ones found elsewhere in this library (TB-500's figure was wrong by 5.6-fold, GHK-Cu's by 15%), but it is an uncertainty rather than a settled number, which is a different kind of problem.

Where the mass comes from structurally

Thirty-nine residues built on a modified GIP scaffold, plus a C20 fatty diacid conjugated through a γGlu-2xOEG linker. The lipid and linker contribute several hundred daltons on top of the peptide backbone, which is why retatrutide is heavier than semaglutide at 4,114 Da despite a comparable residue count.

How to handle the uncertainty

Use whichever figure a certificate of analysis states, and check it by mass spectrometry rather than assuming. Where a supplier's stated mass differs from the commonly quoted 4,731, that is not automatically an error. It may reflect the other reported formula, or a salt form. The absence of an authoritative record means the certificate is the best available reference for a given batch.

Quick reference

CompoundMWVerified in PubChem?
Semaglutide4,114 DaYes (CID 56843331)
Tirzepatide4,813 DaYes (CID 166567236)
Retatrutide~4,731 Da (reported)No record found

Frequently asked questions

What is retatrutide's molecular weight?

Reported as approximately 4,731.33 Da. It cannot be verified against PubChem, which has no retatrutide record.

Why do some sources give a different figure?

At least one reports C228H350N48O66 at ~4,894.58 Da. Without a database entry there is nothing to arbitrate between them.

Which should I use?

Whichever your certificate of analysis states, checked by mass spectrometry. For this compound the certificate is the best available reference.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More Retatrutide Research articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.